C Difficile treatment. Canadian phase 2 clinical trial, recruiting patients.
C Difficile is a gram positive spore forming bacteria, which can cause severe gut infection. It infects and kills 500,000 and 30,000 North Americans respectively every year. Standard of care treatment is Vancomycin antibiotic, which is effective in 60 to 70% of cases. When unsuccessful, the infection can recur and likeliness of recurrence increases after every treatment failure. Its treatment is considered an unmet medical need by the FDA and as such new treatments showing positive potential are typically fast tracked.
ImmuniMed Inc, a Canadian clinical stage Biopharmaceutical company is presently in phase 2 clinical trial of its oral dose antibody treatment and recruiting patients. If you are a Canadian resident, over the age of 18 and have tested positive for C Difficile, please contact us to participate in this trial.
John Hare
John@immunimed.com
204-955-8495
-
53:26
FULL SEND PODCAST
15 days agoWill Smith Gets Deep About Regrets in His Life and Reveals How Much He’s Made Off Movies!
5.51K20 -
10:54
NC Dirt Hunter
4 days agoCivil War relics: Behind Confederate lines. Metal Detecting with the Manticore
11K8 -
3:36
GeekyNerdyTechy
1 day agoPanasonic LUMIX S9: Better Autofocus than S5II & S5IIX
6.55K2 -
1:03:52
TheMonicaCrowleyPodcast
20 hours agoThe Monica Crowley Podcast: Illegal Alien Crime Spree
13K7 -
10:43
History With Kayleigh
1 day agoHave We Found Plato's Body?
14.4K6 -
8:23
Freakin' Reviews
23 hours agoSandwich Storage Showdown: 1 Day & 7 Day Tests!
7.76K10 -
21:06
Cody and Kellie
16 hours ago4X4 Luxury Truck Camper Kitchen Tour + Dinner
15.2K6 -
20:19
Maicy Renee
18 hours agoResults Don't Always Show Progress Made!
10K3 -
7:57
Chris Jericho
1 day agoTalk Is Jericho Highlight: Who Killed WCW x The Rock
16.3K2 -
1:12:44
ReasonTV
16 hours agoIan Vasquez: What Has Javier Milei Accomplished in Argentina?
14.8K2